Literature DB >> 12150932

The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.

Nicolas Preitner1, Francesca Damiola, Luis Lopez-Molina, Joszef Zakany, Denis Duboule, Urs Albrecht, Ueli Schibler.   

Abstract

Mammalian circadian rhythms are generated by a feedback loop in which BMAL1 and CLOCK, players of the positive limb, activate transcription of the cryptochrome and period genes, components of the negative limb. Bmal1 and Per transcription cycles display nearly opposite phases and are thus governed by different mechanisms. Here, we identify the orphan nuclear receptor REV-ERBalpha as the major regulator of cyclic Bmal1 transcription. Circadian Rev-erbalpha expression is controlled by components of the general feedback loop. Thus, REV-ERBalpha constitutes a molecular link through which components of the negative limb drive antiphasic expression of components of the positive limb. While REV-ERBalpha influences the period length and affects the phase-shifting properties of the clock, it is not required for circadian rhythm generation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150932     DOI: 10.1016/s0092-8674(02)00825-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  774 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Genomics and systems approaches in the mammalian circadian clock.

Authors:  Julie E Baggs; John B Hogenesch
Journal:  Curr Opin Genet Dev       Date:  2010-12       Impact factor: 5.578

Review 3.  Regulation of metabolism: the circadian clock dictates the time.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

Review 4.  The circadian epigenome: how metabolism talks to chromatin remodeling.

Authors:  Lorena Aguilar-Arnal; Paolo Sassone-Corsi
Journal:  Curr Opin Cell Biol       Date:  2013-02-04       Impact factor: 8.382

5.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

Authors:  Brian J Altman; Annie L Hsieh; Arjun Sengupta; Saikumari Y Krishnanaiah; Zachary E Stine; Zandra E Walton; Arvin M Gouw; Anand Venkataraman; Bo Li; Pankuri Goraksha-Hicks; Sharon J Diskin; David I Bellovin; M Celeste Simon; Jeffrey C Rathmell; Mitchell A Lazar; John M Maris; Dean W Felsher; John B Hogenesch; Aalim M Weljie; Chi V Dang
Journal:  Cell Metab       Date:  2015-09-17       Impact factor: 27.287

6.  Dynamic postnatal developmental and sex-specific neuroendocrine effects of prenatal polychlorinated biphenyls in rats.

Authors:  Deena M Walker; Benjamin M Goetz; Andrea C Gore
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 7.  Clocking In, Working Out: Circadian Regulation of Exercise Physiology.

Authors:  Drew Duglan; Katja A Lamia
Journal:  Trends Endocrinol Metab       Date:  2019-05-02       Impact factor: 12.015

8.  Nighttime light exposure enhances Rev-erbα-targeting microRNAs and contributes to hepatic steatosis.

Authors:  Patricia C Borck; Thiago M Batista; Jean F Vettorazzi; Gabriela M Soares; Camila Lubaczeuski; Dongyin Guan; Antonio C Boschero; Elaine Vieira; Mitchell A Lazar; Everardo M Carneiro
Journal:  Metabolism       Date:  2018-05-08       Impact factor: 8.694

9.  SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm.

Authors:  Erin Stashi; Rainer B Lanz; Jianqiang Mao; George Michailidis; Bokai Zhu; Nicole M Kettner; Nagireddy Putluri; Erin L Reineke; Lucas C Reineke; Subhamoy Dasgupta; Adam Dean; Connor R Stevenson; Natarajan Sivasubramanian; Arun Sreekumar; Francesco Demayo; Brian York; Loning Fu; Bert W O'Malley
Journal:  Cell Rep       Date:  2014-02-13       Impact factor: 9.423

10.  Circadian rhythm sleep disorders.

Authors:  Lirong Zhu; Phyllis C Zee
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.